AzTrials
AzTrials

Unwanted PregnancyNCT03930576

Consequences of Unwanted Pregnancy in Nepal

An observational study of Unwanted Pregnancy, run by University of California, San Francisco at 1 site in Nepal.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The objective of this project is to examine the health consequences of unwanted pregnancy and denial of legal pregnancy termination services in Nepal on women and their children. Read more about this study

Who is it for?
Ages 15 years and older, women onlyHealthy volunteers can take part
Conditions the study is for
Unwanted Pregnancy
What is being tested?
Receipt of termination services outside of legal setting
How many people
1,436 participants
Where
1 siteNepal
Study dates
16 Apr 2019to 15 Dec 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 15 years and older
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: The proposed study will be a large, longitudinal, prospective, quantitative study among women seeking termination services at 14 diverse facilities in 7 provinces (two facilities in each province) of Nepal. The specific facilities were randomly selected from a list of providers who served more than 60 women in FY 2016/17. Providers who serve more than 60 women per year make up 44% of all providers but provide 92% of termination services. One non-governmental organization and one public site was randomly selected within each of 7 provinces so that their chance of selection was proportionate to the number of women served. These sites are a representative sample of women seeking care.

Who may be able to join

  • women
  • seeking pregnancy termination services at one of the study facilities
  • self-report last menstrual period to be at least 10 weeks ago or not know her gestational age
  • 15 years old or older
  • live in Nepal

Who cannot join

  • under 15 years old
  • not pregnant
  • do not live in Nepal

Trial locations and contacts

1 site in 1 country.

Nepal1 site
  • CREHPA

    Kathmandu

Other trials in Nepal

About this study

Official title: Pregnancy Context and Health

The objective of this project is to examine the health consequences of unwanted pregnancy and denial of legal pregnancy termination services in Nepal on women and their children. The proposed study will be a large, longitudinal, prospective, quantitative study among women seeking termination services at 14 diverse facilities in 7 provinces (two facilities in each province) of Nepal. Every 6 months following baseline, surveys will cover questions about women's physical and mental health, the health and development of their children, as well as measures of family wellbeing, such as residency, relationship status and quality, and extended family relationships, and financial wellbeing, such as employment status, hours of labor, food security, income, and education.

Read the detailed description

The objective of this project is to examine the health consequences of unwanted pregnancy and denial of legal pregnancy termination services in Nepal on women and their children. Births following unwanted pregnancies can be associated with negative physical, social and economic consequences for both the woman and child. Half of all unintended pregnancies are terminated before they are carried to term and, when performed in unsafe or illegal conditions, the consequences can include infection, infertility, and death. The incidence of mortality and morbidity from abortion are notoriously difficult to measure. Widespread stigma associated with unwanted pregnancy - even in settings in which termination is legally available - contribute to misreporting, concealment, and misattribution of termination-related morbidity and mortality. In addition, many women seek illegal methods-both safe and unsafe-which further confounds efforts to measure the prevalence of mortality and morbidity from terminations. The effects of unwanted pregnancy on children, including children born prior to and subsequent to the unwanted pregnancy, are also not well established. A prospective longitudinal study of women with unwanted pregnancies is required to validly investigate the health consequences for women and their families of termination outside of the legal system and delivery of an unwanted pregnancy, as compared to legal termination. Such a study is only possible in places like Nepal, where termination is legal but barriers prevent some women from receiving the service.

Aim 1: To investigate the predictors of denial of legal pregnancy termination services and identify groups of women who may be at elevated risk of adverse sequelae from unwanted pregnancy.

Aim 2: To assess the health consequences for women of childbirth and illegal termination after denial of a legal termination. By comparing the two groups of women denied termination of pregnancy to those obtaining legal procedures, the study team will assess the health effects of denial while accounting for factors associated with experience of unwanted pregnancy.

Aim 3: To measure the effects of legal and illegal termination compared to birth on the health and development of women's existing and subsequent children

Prospective longitudinal data from women in a less developed country would provide valuable evidence for the development of programs and policies globally to improve access to and utilization of safe termination services where they are legal, and harm reduction services for women who are unable to access services.

Being tested
Receipt of termination services outside of legal setting

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Receipt of termination services outside of legal settingOther

    Also called Carrying unwanted pregnancy to term

    This study uses variation in gestational age to examine the impact of receipt of legal termination services compared to denial and receipt outside legal settings and birth.

Study groups in NCT03930576
Study groupRoleWhat they receive
Early Legal TerminationsParticipants who receive a legal termination at <10 weeks gestation at a recruiting facility.
Late Legal TerminationsParticipants who receive a legal termination at 10+ weeks gestation at a recruiting facility.
Turn-aways: Termination outside Legal SettingParticipants who receive a termination at another facility or outside the formal healthcare sector.
Receives: Other: Receipt of termination services outside of legal setting
Turn-aways: BirthParticipants who ultimately carry the pregnancy to term

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Proportion experiencing denial of termination services on day of recruitment

    This will be defined as the proportion of participants who did not receive termination services on the day they were recruited at the clinic site where they are recruited in to the study.

    Measured: 6 weeks

  2. Proportion of participants who did not receive a termination from an approved facility

    Proportion of participants who did not receive termination services from the recruitment clinic and did not receive a termination at any facility that they were referred to by the recruitment facility

    Measured: 6 weeks

  3. Proportion of termination-seeking participants who received a termination

    Participants will report their pregnancy outcome at 6 months; the proportion of participants who had an abortion by 6 months versus had a miscarriage, gave birth, or were still pregnant.

    Measured: 6 months

  4. Proportion of existing children with stunting at 36 months

    The proportion of children existing at the time of termination-seeking who having stunting, or low height-for-age, defined according to the World Health Organization as less than two standard deviations of the World Health Organization Child Growth Standards median.

    Measured: 36 months

  5. Maternal deaths during the study period

    Proportion of maternal deaths by end of study. The study team will implement a verbal autopsy protocol for any women who die during the study period, with a particular focus on identifying specific pregnancy-related causes of death.

    Measured: 36 months

  6. Proportion of women reporting poor health by 36 months

    The proportion of participants who self-report poor or very poor physical health by 36 months.

    Measured: 36 months

  7. Proportion of subsequent children with stunting

    The proportion of subsequent children born to participants after the index pregnancy who having stunting, or low height-for-age, defined according to the World Health Organization as less than two standard deviations of the World Health Organization Child Growth Standards median.

    Measured: 36 months

Secondary outcomes (3)
  1. Proportion experiencing violence from husband at each year of follow up

    Proportion experiencing any physical violence from husband over time (12 months, 24 months, 36 months), defined pushed you, shake you, throw something at you (yes/no), slapped you (yes/no), twisted your arm or pulled your hair (yes/no), punched you (yes/no), kicked you (yes/no), tried to choke you (yes/no), threatened or attacked you with a weapon (yes/no).

    Measured: 36 months

  2. Proportion experiencing violence from any family members or close relatives other than husband at 36 months

    Self-reported violence from family members or close relatives other than husband or partner (yes/no) in the past 12 months.

    Measured: 36 months

  3. Proportion reporting depression at 36 months

    Proportion of participants self-reporting feeling down, depressed or hopeless nearly every day, more than half the days, or several days in the prior two weeks.

    Measured: 36 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Apr 2019
  2. Study start16 Apr 2019
  3. Primary completion15 Dec 2028 (estimated)
  4. Study completion15 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
1,436 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03930576
Sponsor's protocol ID
18-25863
Status last verified
Mar 2026
First submitted
22 Apr 2019
Last updated
11 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Murro R, Raifman S, Boscardin WJ, Puri MC, Karki S, Magar AA, Maharjan DC, Rocca CH, Biggs MA, Diamond-Smith NG, Foster DG. Cohort profile: The Nepal Turnaway Study. medRxiv [Preprint]. 2026 Mar 28:2026.03.10.26348060. doi: 10.64898/2026.03.10.26348060.

    PubMed 41929341

Questions about this trial

What is this clinical trial studying?

An observational study of Unwanted Pregnancy, run by University of California, San Francisco at 1 site in Nepal.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 11 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Nepal. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Proportion experiencing denial of termination services on day of recruitment (time frame: 6 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03930576, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in